193 related articles for article (PubMed ID: 8918323)
1. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
Partsch H; Kechavarz B; Mostbeck A; Köhn H; Lipp C
J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
[TBL] [Abstract][Full Text] [Related]
2. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
Partsch H; Kechavarz B; Köhn H; Mostbeck A
Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
[TBL] [Abstract][Full Text] [Related]
3. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.
Luomanmäki K; Grankvist S; Hallert C; Jauro I; Ketola K; Kim HC; Kiviniemi H; Koskivirta H; Sörskog L; Vilkko P
J Intern Med; 1996 Aug; 240(2):85-92. PubMed ID: 8810934
[TBL] [Abstract][Full Text] [Related]
4. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.
Partsch H; Blättler W
J Vasc Surg; 2000 Nov; 32(5):861-9. PubMed ID: 11054217
[TBL] [Abstract][Full Text] [Related]
5. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
Monreal M; Büller H; Lensing AW; Bonet M; Roncales J; Muchart J; Fraile M
Thromb Haemost; 2002 Dec; 88(6):938-42. PubMed ID: 12529742
[TBL] [Abstract][Full Text] [Related]
6. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group.
Lindmarker P; Holmström M
J Intern Med; 1996 Dec; 240(6):395-401. PubMed ID: 9010387
[TBL] [Abstract][Full Text] [Related]
7. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation.
Partsch H
Vasa; 2001 Jul; 30(3):195-204. PubMed ID: 11582950
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
9. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
12. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
13. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
[TBL] [Abstract][Full Text] [Related]
14. Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: a prospective study.
Partsch H; Oburger K; Mostbeck A; König B; Köhn H
J Vasc Surg; 1992 Nov; 16(5):715-22. PubMed ID: 1433659
[TBL] [Abstract][Full Text] [Related]
15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
16. Could deep vein thrombosis be safely treated at home?
Labas P; Ohradka B; Cambal M
Bratisl Lek Listy; 2001; 102(10):458-61. PubMed ID: 11802292
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.
Shaya SA; Saldanha LJ; Vaezzadeh N; Zhou J; Ni R; Gross PL
J Thromb Haemost; 2016 Jan; 14(1):143-52. PubMed ID: 26514101
[TBL] [Abstract][Full Text] [Related]
18. Dalteparin versus unfractionated heparin in critically ill patients.
; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
[TBL] [Abstract][Full Text] [Related]
19. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
[TBL] [Abstract][Full Text] [Related]
20. Catheter-directed thrombolysis and stenting in the treatment of iliac vein compression syndrome with acute iliofemoral deep vein thrombosis: outcome and follow-up.
Xue GH; Huang XZ; Ye M; Liang W; Zhang H; Zhang JW; Zhang BG
Ann Vasc Surg; 2014 May; 28(4):957-63. PubMed ID: 24440183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
